ONCT
Oncternal Therapeutics, Inc.
Total Trades
14
Buys
13
Sells
1
Largest Trade
$50K–$100K
Insiders
7
Institutional Funds
2
Inst. Value
<$1K
Activist Filings
2
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Wills Robert James | Director | BUY | $15K–$50K | 3K | $8.96 | Apr 11, 2024 |
| Wills Robert James | Director | BUY | $50K–$100K | 7K | $8.48 | Apr 1, 2024 |
| HALE DAVID F | Director | BUY | $1K–$15K | 980 | $9.04 | Feb 27, 2024 |
| Wills Robert James | Director | SELL | $1K–$15K | 980 | $9.04 | Feb 27, 2024 |
| Kaufmann Gunnar F. | Chief Scientific O… | BUY | $1K–$15K | 28K | $0.35 | Jun 14, 2023 |
| BREITMEYER JAMES B | CEO | BUY | $15K–$50K | 150K | $0.29 | Apr 17, 2023 |
| Yazji Salim | Chief Medical Offi… | BUY | $1K–$15K | 25K | $0.29 | Apr 14, 2023 |
| Leavitt Chase C. | General Counsel/Se… | BUY | $1K–$15K | 25K | $0.29 | Apr 14, 2023 |
| VINCENT RICHARD G | CFO | BUY | $1K–$15K | 30K | $0.30 | Apr 14, 2023 |
| VINCENT RICHARD G | CFO | BUY | $1K–$15K | 5K | $1.44 | Mar 28, 2022 |
| VINCENT RICHARD G | CFO | BUY | $15K–$50K | 13K | $1.73 | Jan 31, 2022 |
| Leavitt Chase C. | General Counsel/Se… | BUY | $15K–$50K | 14K | $1.72 | Jan 31, 2022 |
| Yazji Salim | Chief Medical Offi… | BUY | $15K–$50K | 10K | $1.69 | Jan 31, 2022 |
| BREITMEYER JAMES B | CEO | BUY | $15K–$50K | 25K | $1.68 | Jan 31, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| BNP PARIBAS FINANCIAL MARKETS | 182 | <$1K | SH |
| Union Bancaire Privee, UBP SA | 175 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
4.8%
2.9M shares
SC 13G · Jul 8, 2022
2.0%
1.0M shares